Written by Support on 16 January 2017. Posted in Presse- & Adhoc-Mitteilungen. AH: WILEX schließt Antikörper-Lizenzvertrag mit Telix Pharmaceuticals Limited ab PDF File: images/files//2023/6373aea7e66f4_20170116_AH_WILEX_Telix_Redectane_dt_final.pdf 2017 Created on 15 November 2022. Last updated on 15 November 2022. Hits: 1182 Prev Next